• Microvascular disease features emerge as early and cross-cutting indicators of diabetes complications, with retinal pattern changes, limited joint mobility serving as microvascular surrogates, and hypertension-associated risk observed across juvenile and adult cohorts. [10], [4], [13], [12]

• Epidemiology and prognosis show geographic, age-at-onset, and survivorship variability, reflecting diverse incidence rates and long-term outcomes across populations and time. [1], [14], [15]

• Biochemical and metabolic pathways connect diabetes to cardiovascular risk, evidenced by altered cholesterol metabolism, insulin and glucose response patterns, and impaired glucose tolerance across diverse populations. [5], [7], [19], [20]

• Pregnancy and reproductive factors modulate prognosis and late complications, while longitudinal studies of juvenile IDDM reveal progression patterns and outcome trajectories. [12], [9]

• Public health surveillance and population screening highlight early detection and regional differences, informing prevention strategies and resource planning. [1], [18]